drugset / Trial / NCT00793520

Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia

NCT00793520

Phase 3 Terminated 2 enrolled Forest Laboratories
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effect of milnacipran on how the brain processes pain in patients with fibromyalgia and to assess the relationship between this effect and brain activation patterns during functional magnetic resonance imaging.

Timeline

Start
2008-11
Primary completion
2009-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified Oral

Indications